MedPath

Inlyta

Brand Name: Inlyta

Generic Name: Axitinib

Active
Registration Number

DR-XY43764

Dosage Form

Film-Coated Tablet `

Issuance Date

August 28, 2024

Expiry Date

October 2, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5 mg
PackagingAlu/Alu blister pack x 14's (Box of 28's, 56's and 140's)

Classification

C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Tyrosine Kinase Inhibitor
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

AxitinibActive
Monograph: Axitinib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform